Gene ID 4790
Formulation 50 µg (0.5 mg/ml) in phosphate buffered saline (PBS), pH 7.2, containing 50% glycerol, 1% BSA and 0.02% thimerosal.
Antibody Target NFkB p105
Shipping gel pack
Concentration 0.5 mg/ml
Storage Temp. -20 °C
Appearance Colorless liquid
Research Use For Rersearch Use Only! Not to be used in humans.
Shelf Life 1 year
Handling The peptide solution should be gently mixed before use.
Test You can block the antibody by the specific target amino acid sequence of peptide.
Properties blocking peptide
Gene NF-κB (nuclear factor kappa-light-chain-enhancer of activated B cells) is a protein complex that controls transcription of DNA, cytokine production and cell survival. NF-κB is found in almost all animal cell types and is involved in cellular responses to stimuli such as stress, cytokines, free radicals, ultraviolet irradiation, oxidized LDL, and bacterial or viral antigens. NF-κB plays a key role in regulating the immune response to infection (κ light chains are critical components of immunoglobulins). Incorrect regulation of NF-κB has been linked to cancer, inflammatory and autoimmune diseases, septic shock, viral infection, and improper immune development. NF-κB has also been implicated in processes of synaptic plasticity and memory
Description Peptides short amino acid chains or epitopes or blocking antagonists. The shortest peptides are dipeptides, consisting of 2 amino acids joined by a single peptide bond, followed by tripeptides, tetra peptides, ... till polypeptides that are long, continuous, and unbranched synthetic peptide chains. These biological oligomers and polymers can be Solid-phase peptide synthesis (SPPS), or in continue produced for custom peptide synthesis projects. The High-efficiency solid phase peptide synthesis (HE-SPPS) is give very low production costs.
Short name NFkB p105 Blocking Peptide
Technique blocking peptide, Blocking, peptide
Alternative name NFkB p105 inhibiting short protein sequence
Alternative technique control